Sartorius Stedim Biotech S.A. (VIE:DIM)

Market Cap	16.45B -12.4%
Revenue (ttm)	2.97B +6.7%
Net Income	265.60M +51.7%
EPS	2.73 +50.9%
Shares Out	n/a
PE Ratio	61.95
Forward PE	32.90
Dividend	0.69 (0.42%)
Ex-Dividend Date	Mar 31, 2026

Volume	n/a
Average Volume	n/a
Open	165.45
Previous Close	166.90
Day's Range	163.60 - 165.45
52-Week Range	151.15 - 222.60
Beta	n/a
RSI	40.91
Earnings Date	Apr 23, 2026

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Laboratory Analytical Instruments
• Founded: 1978
• Employees: 10,009
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DIM

Financial Performance

In 2025, Sartorius Stedim Biotech's revenue was 2.97 billion, an increase of 6.74% compared to the previous year's 2.78 billion. Earnings were 265.60 million, an increase of 51.68%.